Issued Patents All Time
Showing 25 most recent of 37 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12365899 | RNAi agents and compositions for inhibiting expression of apolipoprotein C-III (APOC3) | Rui Zhu, Tao Pei, Steven B. Kanner, So Wong | 2025-07-22 |
| 12221610 | RNAi agents for inhibiting expression of HIF-2 alpha (EPAS1), compositions thereof, and methods of use | Dongxu Shu, Anthony Nicholas, Rui Zhu, Jeffrey C. Carlson, So Wong +4 more | 2025-02-11 |
| 12173086 | Alpha-v beta-6 integrin ligands and uses thereof | Aaron Almeida, Erik W. Bush, Tao Pei, Agnieszka Glebocka, Anthony Nicholas +2 more | 2024-12-24 |
| 12116573 | Targeting ligands for therapeutic compounds | David B. Rozema, Darren H. Wakefield, Andrei V. Blokhin, Jonathan D. Benson, Tao Pei +1 more | 2024-10-15 |
| 12065458 | Trialkyne linking agents and methods of use | Erich Altenhofer, Jeffrey C. Carlson, Matthew Fowler-Watters, Bo Chen | 2024-08-20 |
| 12042509 | Prekallikrein-modulating compositions and methods of use thereof | Rui Zhu, Zhiqing (Joel) Zhou, Kimberly Fultz, Sean Studer | 2024-07-23 |
| 11884920 | Alpha-1 antitrypsin (AAT) RNAi agents, compositions including AAT RNAi agents, and methods of use | Rui Zhu, Christine I. Wooddell, Tao Pei | 2024-01-30 |
| 11753473 | Anti-PD-L1 antibodies | Xueming Qian, Teng Fei | 2023-09-12 |
| 11597701 | Integrin ligands and uses thereof | Xiaokai Li, Erik W. Bush, Rui Zhu, Dongxu Shu, Jonathan D. Benson +2 more | 2023-03-07 |
| 11590156 | RNAi agents for hepatitis B virus infection | Rui Zhu, Christine I. Wooddell, Bruce D. Given, Tao Pei, David L. Lewis +3 more | 2023-02-28 |
| 11517584 | RNAi agents for Hepatitis B virus infection | Rui Zhu, Christine I. Wooddell, Bruce D. Given, Tao Pei, David L. Lewis +3 more | 2022-12-06 |
| 11492624 | RNAi agents and compositions for inhibiting expression of Asialoglycoprotein receptor 1 | Tao Pei, Rui Zhu, Bruce D. Given, Stacey Melquist | 2022-11-08 |
| 11214802 | RNAi agents for inhibiting expression of alpha-ENaC and methods of use | Rui Zhu, Tao Pei, Anthony Nicholas, Erik W. Bush | 2022-01-04 |
| 11214801 | RNAi agents and compositions for inhibiting expression of apolipoprotein C-III (APOC3) | Rui Zhu, Tao Pei, Steven B. Kanner, So Wong | 2022-01-04 |
| 11203756 | Alpha-1 antitrypsin (AAT) RNAi agents, compositions including AAT RNAi agents, and methods of use | Rui Zhu, Christine I. Wooddell, Tao Pei | 2021-12-21 |
| 11180529 | Alpha-v beta-6 integrin ligands and uses thereof | Aaron Almeida, Erik W. Bush, Tao Pei, Agnieszka Glebocka, Anthony Nicholas +2 more | 2021-11-23 |
| 11174481 | Targeting ligands | Tao Pei, Agnieszka Glebocka, Michael Lawler, Fred J. Fleitz, Erich Altenhofer +1 more | 2021-11-16 |
| 11078227 | 5′-cyclo-phosphonate modified nucleotides | Tao Pei, Michael Lawler | 2021-08-03 |
| 10995335 | RNAi agents and compositions for inhibiting expression of angiopoietin-like 3 (ANGPTL3), and methods of use | Rui Zhu, So Wong | 2021-05-04 |
| 10822416 | Anti-PD-L1 antibodies | Xueming Qian, Teng Fei | 2020-11-03 |
| 10780108 | RNAi agents for Hepatitis B virus infection | Rui Zhu, Christine I. Wooddell, Bruce D. Given, Tao Pei, David L. Lewis +3 more | 2020-09-22 |
| 10662427 | Compositions and methods for inhibiting gene expression of LPA | Stacey Melquist, Steven B. Kanner, David B. Rozema, David L. Lewis, Lauren J. Almeida +4 more | 2020-05-26 |
| 10597657 | RNAi agents and compositions for inhibiting expression of apolipoprotein C-III (APOC3) | Rui Zhu, Tao Pei, Steven B. Kanner, So Wong | 2020-03-24 |
| 10590416 | RNAi agents for inhibiting expression of alpha-ENaC and methods of use | Rui Zhu, Tao Pei, Anthony Nicholas, Erik W. Bush | 2020-03-17 |
| 10450565 | Alpha-1 antitrypsin (AAT) RNAi agents, compositions including AAT RNAi agents, and methods of use | Rui Zhu, Christine I. Wooddell, Tao Pei | 2019-10-22 |